NCSD
@ncsddc.bsky.social
Located in the nation's capital, NCSD is a national public health membership organization representing health department STD directors, their support staff, and community-based partners across 50 states, seven large cities, and five US territories.
Reposted by NCSD
WHO warns of rising, worrisome levels of drug-resistant gonorrhea
Data from a new surveillance report show rising resistance to ceftriaxone and cefixime, the two antibiotics currently recommended for gonorrhea treatment.
www.cidrap.umn.edu/g...
Data from a new surveillance report show rising resistance to ceftriaxone and cefixime, the two antibiotics currently recommended for gonorrhea treatment.
www.cidrap.umn.edu/g...
November 19, 2025 at 8:03 PM
WHO warns of rising, worrisome levels of drug-resistant gonorrhea
Data from a new surveillance report show rising resistance to ceftriaxone and cefixime, the two antibiotics currently recommended for gonorrhea treatment.
www.cidrap.umn.edu/g...
Data from a new surveillance report show rising resistance to ceftriaxone and cefixime, the two antibiotics currently recommended for gonorrhea treatment.
www.cidrap.umn.edu/g...
Access uncertain for new injectable PrEP as the Affordable Care Act's (ACA) open enrollment begins. Read more: www.kff.org/hiv-aids/acc...
Access Uncertain for New Injectable PrEP as the Affordable Care Act’s (ACA) Open Enrollment Begins | KFF
This analysis examines access to, and consumers ability to find information on, a new twice annual long-acting PrEP drug during the first ACA open enrollment period since its approval. Despite the dru...
www.kff.org
November 19, 2025 at 4:17 PM
Access uncertain for new injectable PrEP as the Affordable Care Act's (ACA) open enrollment begins. Read more: www.kff.org/hiv-aids/acc...
Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study. Read more: www.aidsmap.com/news/nov-202...
Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study
An antibody from a Tanzanian woman discovered during screening for anti-HIV antibodies shows a strong therapeutic potential in a preclinical study. Named 04_A06, it neutralised (blocked) 97.3% of over...
www.aidsmap.com
November 10, 2025 at 3:31 PM
Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study. Read more: www.aidsmap.com/news/nov-202...
New guidelines suggest treating male sexual partners to try to lower the risk of patients passing BV back and forth to each other. Read more: www.self.com/story/bacter...
Got Persistent BV? This New Treatment Approach May Help
It involves a little teamwork.
www.self.com
October 23, 2025 at 3:30 PM
New guidelines suggest treating male sexual partners to try to lower the risk of patients passing BV back and forth to each other. Read more: www.self.com/story/bacter...
Los Angeles County documents second case of locally acquired clade 1 mpox. Read more: www.cidrap.umn.edu/mpox/los-ang...
Los Angeles County documents 2nd case of locally acquired clade 1 mpox
The county announced the detection yesterday, and it involves an adult with no recent travel to mpox-endemic areas.
www.cidrap.umn.edu
October 17, 2025 at 6:19 PM
Los Angeles County documents second case of locally acquired clade 1 mpox. Read more: www.cidrap.umn.edu/mpox/los-ang...
Reposted by NCSD
Ramifications from a shutdown on public health systems and programs will be felt far beyond Washington, halting almost all of the federal government’s nonessential functions, including many related to public health.
kffhealthnews.org/news/article...
kffhealthnews.org/news/article...
Shutdown Halts Some Health Services as Political Risks Test Parties’ Resolve - KFF Health News
Congressional Democrats and Republicans are at an impasse in negotiations. Which side will blink first?
kffhealthnews.org
October 1, 2025 at 2:29 PM
Ramifications from a shutdown on public health systems and programs will be felt far beyond Washington, halting almost all of the federal government’s nonessential functions, including many related to public health.
kffhealthnews.org/news/article...
kffhealthnews.org/news/article...
The 2024 STI Surveillance Data was released today by the CDC!
Cases of chlamydia, gonorrhea, and primary & secondary syphilis declined from the year prior, but are all at higher levels than they were ten years ago, signaling there's still progress to be made. Read more: www.cdc.gov/sti-statisti...
Cases of chlamydia, gonorrhea, and primary & secondary syphilis declined from the year prior, but are all at higher levels than they were ten years ago, signaling there's still progress to be made. Read more: www.cdc.gov/sti-statisti...
Sexually Transmitted Infections Surveillance, 2024 (Provisional)
The most recent national data for reportable STIs: chlamydia, syphilis, gonorrhea.
www.cdc.gov
September 24, 2025 at 3:46 PM
The 2024 STI Surveillance Data was released today by the CDC!
Cases of chlamydia, gonorrhea, and primary & secondary syphilis declined from the year prior, but are all at higher levels than they were ten years ago, signaling there's still progress to be made. Read more: www.cdc.gov/sti-statisti...
Cases of chlamydia, gonorrhea, and primary & secondary syphilis declined from the year prior, but are all at higher levels than they were ten years ago, signaling there's still progress to be made. Read more: www.cdc.gov/sti-statisti...
Reposted by NCSD
@ncsddc.bsky.social is implementing a coordinated national strategy to strengthen the disease intervention (DI) workforce by developing high-quality, standardized training and continuing education via ASPPH’s UniversiDI to the US disease intervention (DI) workforce.
September 15, 2025 at 6:12 PM
@ncsddc.bsky.social is implementing a coordinated national strategy to strengthen the disease intervention (DI) workforce by developing high-quality, standardized training and continuing education via ASPPH’s UniversiDI to the US disease intervention (DI) workforce.
Study shows one dose of benzathine penicillin G successfully treated early syphilis just as well as the three-injection regimen. Read more: www.nih.gov/news-events/...
One dose of antibiotic treats early syphilis as well as three doses
NIH-funded clinical trial shows potential to simplify treatment for early syphilis.
www.nih.gov
September 5, 2025 at 2:01 PM
Study shows one dose of benzathine penicillin G successfully treated early syphilis just as well as the three-injection regimen. Read more: www.nih.gov/news-events/...
It's #NationalSeniorCitizenDay today! Read more about how sex changes in your golden years: www.huffpost.com/entry/sex-af...
9 Things No One Tells You About Sex After 70
Yes, there's a high likelihood that your parents and grandparents are still having sex.
www.huffpost.com
August 21, 2025 at 5:56 PM
It's #NationalSeniorCitizenDay today! Read more about how sex changes in your golden years: www.huffpost.com/entry/sex-af...
In June, the U.S. FDA approved the breakthrough HIV prevention drug Yeztugo (lenacapavir), which requires just two shots annually. However, questions loom about whether enough people who could benefit from the drug will take it. Read more: www.thebody.com/news/hiv/mor...
We Have More PrEP Options Than Ever—But Who Will Be Able To Afford Them?
HIV advocates worry the high sticker price for brand-name PrEP—including long-acting injectables—will limit access, especially as federal support wavers.
www.thebody.com
August 19, 2025 at 5:36 PM
In June, the U.S. FDA approved the breakthrough HIV prevention drug Yeztugo (lenacapavir), which requires just two shots annually. However, questions loom about whether enough people who could benefit from the drug will take it. Read more: www.thebody.com/news/hiv/mor...
The Partnership to End HIV, STD, and Hepatitis calls for immediate release of Ryan White Part F funding. Read more: apnews.com/press-releas...
Partnership to End HIV, STD, and Hepatitis Calls For Immediate Release of Ryan White Part F Funding
WASHINGTON, DC, UNITED STATES, August 8, 2025 / EINPresswire.com / -- The Partnership to End HIV, STDs, and Hepatitis is deeply concerned about recent reports that the Trump Administration is planning...
apnews.com
August 11, 2025 at 2:43 PM
The Partnership to End HIV, STD, and Hepatitis calls for immediate release of Ryan White Part F funding. Read more: apnews.com/press-releas...
"Anytime you're throwing a threat into the mix that someone's freedom could be harmed, it's going to make people shut down; they're not going to show up for healthcare services," Elizabeth Finley of NCSD told MedPage Today. Read more: www.medpagetoday.com/infectiousdi...
ID Experts Pan Trump Order Calling for Forced Hospitalization of Homeless People
Another example of 'throwing out a policy without input from experts,' says HIVMA chair
www.medpagetoday.com
July 31, 2025 at 3:04 PM
"Anytime you're throwing a threat into the mix that someone's freedom could be harmed, it's going to make people shut down; they're not going to show up for healthcare services," Elizabeth Finley of NCSD told MedPage Today. Read more: www.medpagetoday.com/infectiousdi...
The Senate on Tuesday confirmed Susan Monarez to be President Donald Trump’s director of the U.S. Centers for Disease Control and Prevention. Read more: www.statnews.com/2025/07/29/s...
Susan Monarez confirmed as Trump's CDC director
The Senate on Tuesday confirmed Susan Monarez to be President Trump’s director of the Centers for Disease Control and Prevention.
www.statnews.com
July 30, 2025 at 2:30 PM
The Senate on Tuesday confirmed Susan Monarez to be President Donald Trump’s director of the U.S. Centers for Disease Control and Prevention. Read more: www.statnews.com/2025/07/29/s...
US State Department officials are developing a plan to transform the President’s Emergency Plan for AIDS Relief (PEPFAR) from an entity that tackles HIV to one that is broadly focused on protecting and promoting American interests. Read more: healthpolicy-watch.news/us-officials...
US Drafts Plan To Change PEPFAR's Focus From HIV To Diseases That Could Threaten Americans - Health Policy Watch
US State Department officials are developing a plan to transform the President’s Emergency Plan for AIDS Relief (PEPFAR) from an entity that tackles HIV to
healthpolicy-watch.news
July 25, 2025 at 1:45 PM
US State Department officials are developing a plan to transform the President’s Emergency Plan for AIDS Relief (PEPFAR) from an entity that tackles HIV to one that is broadly focused on protecting and promoting American interests. Read more: healthpolicy-watch.news/us-officials...
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, following a July 10 recall of certain lots of Bicillin L-A that were found to be contaminated with floating particles. Read more: www.cnn.com/2025/07/16/h...
A new recall of injected penicillin may put gains against syphilis in peril | CNN
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during preg...
www.cnn.com
July 17, 2025 at 2:21 PM
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, following a July 10 recall of certain lots of Bicillin L-A that were found to be contaminated with floating particles. Read more: www.cnn.com/2025/07/16/h...
Reposted by NCSD
#Breaking: The Senate passed a $4.5 trillion tax cut bill after last-minute changes to its health care provisions, as Republicans scrambled to get their party on board.
www.statnews.com/2025/07/01/s...
www.statnews.com/2025/07/01/s...
Senate passes Trump’s tax-cut bill that would slash Medicaid spending
The Senate has passed a $4.5 trillion tax cut bill after last-minute changes to its health care provisions, as Republicans scrambled to get their party on board.
www.statnews.com
July 1, 2025 at 4:12 PM
#Breaking: The Senate passed a $4.5 trillion tax cut bill after last-minute changes to its health care provisions, as Republicans scrambled to get their party on board.
www.statnews.com/2025/07/01/s...
www.statnews.com/2025/07/01/s...
Reposted by NCSD
The FDA approved twice-yearly lenacapavir (Yeztugo) for PrEP, making it the longest-acting HIV prevention method. Advocates lauded the eagerly awaited approval but expressed concern that the $28,000 annual price tag could limit access as HIV prevention funding is being slashed in the US & worldwide.
FDA Approves Twice-Yearly Lenacapavir for HIV Prevention
More than 99% of people who received Yeztugo in two large clinical trials remained HIV negative.
www.poz.com
June 19, 2025 at 1:06 AM
The FDA approved twice-yearly lenacapavir (Yeztugo) for PrEP, making it the longest-acting HIV prevention method. Advocates lauded the eagerly awaited approval but expressed concern that the $28,000 annual price tag could limit access as HIV prevention funding is being slashed in the US & worldwide.
The Food and Drug Administration approved Wednesday a powerful new drug that provides nearly complete protection against HIV infection with just a single administration every six months. Read more: www.statnews.com/2025/06/18/f...
HIV protection with just two shots a year: FDA approves Gilead drug
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the current political climate.
www.statnews.com
June 18, 2025 at 6:31 PM
The Food and Drug Administration approved Wednesday a powerful new drug that provides nearly complete protection against HIV infection with just a single administration every six months. Read more: www.statnews.com/2025/06/18/f...
The staff of two world-class laboratories at the Centers for Disease Control and Prevention that were slated to be closed in a round of cuts announced in April have been informed that their terminations have been canceled. Read more: www.statnews.com/2025/06/16/c...
CDC workers fired from prominent STI, hepatitis labs are rehired
The staff of two world-class CDC laboratories that were slated to be closed by the Trump administration have been informed that their terminations have been canceled.
www.statnews.com
June 17, 2025 at 5:28 PM
The staff of two world-class laboratories at the Centers for Disease Control and Prevention that were slated to be closed in a round of cuts announced in April have been informed that their terminations have been canceled. Read more: www.statnews.com/2025/06/16/c...
“This lab is critical to America’s public health, and the health and livelihood of Americans will be worse off without it,” David C. Harvey, MSW, executive director of the National Coalition of STD Directors, told Healio. Read more: www.healio.com/news/infecti...
Closed CDC lab was cornerstone of national, global STI science
The Trump administration closed a CDC lab that tracked STIs, including drug-resistant gonorrhea. Experts have painted a grim picture of STI surveillance in the wake of the lab's closing.
www.healio.com
June 9, 2025 at 2:14 PM
“This lab is critical to America’s public health, and the health and livelihood of Americans will be worse off without it,” David C. Harvey, MSW, executive director of the National Coalition of STD Directors, told Healio. Read more: www.healio.com/news/infecti...
David C. Harvey, Executive Director of NCSD, talks congenital syphilis during STI Engage, our annual conference, held in Phoenix this year. Read more: www.kjzz.org/politics/202...
Congenital syphilis is on the rise in Arizona. But RFK Jr. didn't mention it in kids health report
Congenital syphilis occurs when a pregnant woman with the sexually-transmitted disease passes the infection to her baby in the womb. Cases are on the rise here in Arizona, and there's a national push ...
www.kjzz.org
June 5, 2025 at 5:14 PM
David C. Harvey, Executive Director of NCSD, talks congenital syphilis during STI Engage, our annual conference, held in Phoenix this year. Read more: www.kjzz.org/politics/202...
WHO is convening a Guideline Development Group (GDG) for the development of evidence-based clinical guidelines on doxycycline prophylaxis for prevention of STIs. Read more: www.who.int/news/item/28...
WHO announces the development of recommendations on doxycycline prophylaxis for the prevention of sexually transmitted infections
WHO is convening a Guideline Development Group for the development of Clinical guidelines on doxycycline prophylaxis for prevention of sexually transmitted infections. Members of the public and intere...
www.who.int
May 28, 2025 at 5:37 PM
WHO is convening a Guideline Development Group (GDG) for the development of evidence-based clinical guidelines on doxycycline prophylaxis for prevention of STIs. Read more: www.who.int/news/item/28...
Copper IUDs are associated with an increased risk for several STIs and other vaginal conditions than IUDs containing levonorgestrel, according to a retrospective chart review presented at the ACOG 2025 Annual Meeting. Read more: www.medscape.com/viewarticle/...
Copper IUDs Linked to Higher Risk for STI Than Hormonal IUDs
Pelvic inflammatory disease risk remains lower with copper IUDs than with levonorgestrel IUDs.
www.medscape.com
May 22, 2025 at 3:40 PM
Copper IUDs are associated with an increased risk for several STIs and other vaginal conditions than IUDs containing levonorgestrel, according to a retrospective chart review presented at the ACOG 2025 Annual Meeting. Read more: www.medscape.com/viewarticle/...
Prof Andrew Pollard, the chair of the Joint Committee on Vaccination and Immunisation (JCVI), which recommended the vaccine, said despite it only being 30% effective, it was "worth having" and could have "a huge impact" overall. Read more: www.bbc.com/news/article...
Gonorrhoea vaccine to be rolled out in England from August
The treatment will be offered to those most at risk from August after a record number of cases.
www.bbc.com
May 21, 2025 at 5:58 PM
Prof Andrew Pollard, the chair of the Joint Committee on Vaccination and Immunisation (JCVI), which recommended the vaccine, said despite it only being 30% effective, it was "worth having" and could have "a huge impact" overall. Read more: www.bbc.com/news/article...